The new 8,000-square-foot building will support oligonucleotide manufacturing for molecular biology applications such as qPCR, next-generation sequencing, and synthetic biology.
The three viruses targeted by the assay are covered under a California law requiring the testing of citrus nursery trees.
The company issued more than 8.6 million shares at €11.50 per share in its IPO. Its shares list on Euronext Brussels under ticker symbol "BCART."
Bioyoung becomes the fifth certified service provider for Agena's MassArray platform in China and Taiwan.
The deal follows Linkage's launch of a European subsidiary in Geneva.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.